![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, November 17, 2021 1:55:48 PM
"Initial feasibility work to formulate Brilacidin for potential prophylactic use via inhaled delivery, to leverage Brilacidin’s unique virucidal and blocking antiviral properties, also is underway."
http://www.ipharminc.com/press-release/2021/11/12/innovation-pharmaceuticals-conducting-full-data-analysis-of-phase-2-brilacidin-covid-19-trial-results-to-support-brilacidins-potential-inclusion-in-government-sponsored-covid-19-trials
Contrary to recent criticism of your post, protein based inhaled drugs are currently approved therapeutics { eg insulin and many others} and more are being studied. See table 1. from the link below.
https://link.springer.com/article/10.1186/s43556-020-00014-z
239 peptide or protein based drugs are reported to be approved in this 2017 data base.
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0181748
The article is a good review of the promises and technical issues in formulating inhaled drugs.
Inhaled drugs are now commonly used. Many people with asthma and COPD use inhaled pharmaceuticals. Ask someone with severe asthma where their inhalers are and they frequently will pull them out of their pockets or purses.
http://www.ipharminc.com/press-release/2021/11/12/innovation-pharmaceuticals-conducting-full-data-analysis-of-phase-2-brilacidin-covid-19-trial-results-to-support-brilacidins-potential-inclusion-in-government-sponsored-covid-19-trials
Brilacidin will not be the first drug for covid where an inhaler was studied. Gilead has completed a clinical trial for remdesivir to be used as an inhaler.
https://clinicaltrials.gov/ct2/show/NCT04539262
Many inhaled drugs, including peptides and proteins, have been approved and many more are being studied. Given Brilacidin's potent antiviral in vitro studies as well as its safety it is more than reasonable to study Brilacidin as an inhaled therapeutic.
GLTA Farrell
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM